BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  Zymeworks Reports Third Quarter 2017 Financial Results and Provides Business Update

  Revenues for the three months ended September 30, 2017 were $0.1 million compared to $2.2 million for the same period of 2016.

  November 8, 2017

   · 

  7 min read
• Business

  AmpliPhi Biosciences to Hold 2017 Third Quarter and Business Update Conference Call on November 14

  AmpliPhi Biosciences announced that management will hold a business update conference call on Tuesday, November 14, 2017 beginning at 4:30 p.m. Eastern time (1:30 p.m. Pacific time).

  November 8, 2017

   · 

  1 min read
• Business

  Invitae Corporation Issues Reminder Regarding Exchange Offer for CombiMatrix Corporation Series F Warrants

  Exchange offer to expire one minute after 11:59 p.m., New York City time, on November 13, 2017, unless extended.

  November 8, 2017

   · 

  10 min read
• Drug Development

  vTv Therapeutics Initiates Phase 1b/2 Study Evaluating TTP399 for the Treatment of Type 1 Diabetes

  Results from the Phase1b part of the study are expected in early 2018.

  November 8, 2017

   · 

  6 min read
• Business

  Phagelux Announces a Multi-Product Collaboration With Passport Food Safety Solutions

  Phagelux’s U.S. operating division has entered into an agreement to develop for Passport Food Safety four bacteriophage-based products to be used for a variety of food safety and environment protection purposes.

  November 8, 2017

   · 

  2 min read
• Business

  Novus Therapeutics Reports Third Quarter 2017 Results

  For the third quarter of 2017, Novus reported a net loss of $3.0 million, or $0.43 loss per share, compared to a net loss of $2.0 million, or $4.35 loss per share, for the same period in 2016.

  November 8, 2017

   · 

  16 min read
• Lone Star Bio

  DisperSol Technologies Announces New R&D Data to Be Presented at 2017 Annual Meeting of AAPS

  The symposium will highlight partners’ experiences with KinetiSol: a novel manufacturing technology for making amorphous solid dispersions of poorly water-soluble drug molecules to enhance their bioavailability & clinical effectiveness.

  November 8, 2017

   · 

  2 min read
• Business

  Aeterna Zentaris Reports Third Quarter 2017 Financial and Operating Results

  Revenues were $241,000 and $745,000 for the three and nine months ended September 30, 2017, as compared to $269,000 and $607,000 for the same periods in 2016.

  November 8, 2017

   · 

  13 min read
• Business

  Alliar Announces 3Q17 Results

  Net revenue1 growth of 14.0% in Q3, with same store sales of 7%. YTD growth of 18.0%, SSS of 11%.

  November 8, 2017

   · 

  1 min read
• Important Tax Notice to U.S. Shareholders of Portage Biotech

  This statement is provided for shareholders who are United States persons for purposes of the U.S. Internal Revenue Code of 1986, as amended and the related United States Treasury regulations.

  November 8, 2017

   · 

  2 min read